Skip to main content
Editor's Message

Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 articles from 2024.


2024 Top 10 Articles

Acute Coronary Occlusion and Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest

Ronstan Lobo, MB, BCh, BAO; Dhruv Sarma, BM, BCh; Meir Tabi, MD; Gregory W. Barsness, MD; Abhiram Prasad, MD; Malcolm R. Bell, MD; Jacob C. Jentzer, MD

J INVASIVE CARDIOL 2024;36(1). doi:10.25270/jic/23.00115


Sensor-Guided Transcatheter Aortic Valve Replacement

Julio Farjat-Pasos, MD, MSc; Réda Ibrahim, MD; Janarthanan Sathananthan, MBCHB, MPH; Jean-Michel Paradis, MD; Anthony Poulin, MD; Anita W. Asgar, MD, MSc; Jean-François Dorval, MD; Richard Cook, MD, MSc; Josep Rodés-Cabau, MD, PhD

J INVASIVE CARDIOL 2024;36(2). doi:10.25270/jic/23.00242


Coronary Physiology Instantaneous Wave-Free Ratio (iFR) Derived From X-Ray Angiography Using Artificial Intelligence Deep Learning Models: A Pilot Study

Miguel Nobre Menezes, MD, MSc; João Lourenço Silva, MSc Beatriz Silva, MD; Rita Marante de Oliveira, BSc; Tiago Rodrigues, MD; Arlindo L. Oliveira, PhD; Fausto J. Pinto, PhD

J INVASIVE CARDIOL 2024;36(3). doi:10.25270/jic/23.00285

Watch the accompanying author interview.


Update on Chronic Total Occlusion Percutaneous Coronary Intervention

Deniz Mutlu, MD; Athanasios Rempakos, MD; Michaella Alexandrou, MD; Ahmed Al-Ogaili, MD; Masahisa Yamane, MD; Khaldoon Alaswad, MD; Mir Basir, MD; Rhian Davies, DO; James Choi, MD; Andrea Gagnor, MD; Roberto Garbo, MD; Omer Goktekin, MD; Sevket Gorgulu, MD; Jaikirshan J. Khatri, MD; William Nicholson, MD; Stephane Rinfret, MD; Wissam Jaber, MD; Mohaned Egred, MD; Anastasios Milkas, MD; Carlo Di Mario, MD; Kambis Mashayekhi, MD; Yader Sandoval, MD; M. Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD

J INVASIVE CARDIOL 2024;36(3). doi:10.25270/jic/23.00239

Watch the accompanying author interview.


A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions

Luigi Di Serafino, MD, PhD; Maurizio Turturo, MD; Claudio Larosa, MD; Maria Scalamogna, MD; Plinio Cirillo, MD, PhD; Vito Alessandro Angelilli; Saverio Lanzone, MD; Francesco Bartolomucci, MD, PhD; Riccardo Granata, MD; Francesco Saverio Rea, MD; Raffaele Piccolo, MD, PhD; Anna Franzone, MD, PhD; Giuseppe Gargiulo, MD, PhD; Carmen Anna Maria Spaccarotella, MD, PhD; Eugenio Stabile,MD, PhD; Giovanni Esposito, MD, PhD

J INVASIVE CARDIOL 2024;36(5). doi:10.25270/jic/23.00302


Hybrid Robotic-Assisted Coronary Revascularization and Transcatheter Aortic Valve Replacement: A Single-Center Experience

Yoshiyuki Yamashita, MD, PhD; Serge Sicouri, MD, PhD; Gianluca Torregrossa, MD; William A. Gray, MD; Francis P. Sutter, DO; Basel Ramlawi, MD

J INVASIVE CARDIOL 2024;36(6). doi:10.25270/jic/23.00308


Transient Internal Mammary Artery Graft Stenosis on Early Angiography: Navigating Pitfalls in Hybrid Myocardial Revascularization

Per Lehnert, MD, PhD; Troels Thim, MD, PhD; Lars Jakobsen, MD, PhD; Michael Mæng, MD, PhD; Evald Høj Christiansen, MD, PhD; Ivy Susanne Modrau, MD

J INVASIVE CARDIOL 2024;36(7). doi:10.25270/jic/24.00025


Complex Percutaneous Coronary Intervention in Patients Unable to Undergo Coronary Artery Bypass Grafting During the COVID-19 Pandemic: Insights From the UK-ReVasc Registry

Thomas A. Kite, MD, PhD; Alexander Chase, MD, PhD; Colum G. Owens, MD; Aadil Shaukat, MD; Abdul M. Mozid, MD; Peter O’Kane, MD; Helen Routledge, MD; Divaka Perera MD, PhD; Ajay K. Jain, MD; Nick Palmer, MD; Stephen P. Hoole, MD; Mohaned Egred, MD; Manas K. Sinha, MD; Thomas J. Cahill, MD, PhD; Brijesh Anantharam, MD; Jonathan Byrne, MD; Paul D. Morris,MD, PhD; Sharon Kean; Ahmed Sabra, MD; Muhammad Aetesam-ur-Rahman, MD; Jonathan Mailey, MD; Ozan Demir, MD, PhD; Kyriacos Mouyis, MD; Ahmed Abdalwahab, MD; Dimitrios Terentes-Printzios, MD; Ritesh Kanyal, MD; Nick Curzen, MD, PhD; Colin Berry, MD, PhD; Anthony H. Gershlick, MD; Andrew Ladwiniec, MD; on behalf of the UK-ReVasc Registry Investigators

J INVASIVE CARDIOL 2024;36(7). doi:10.25270/jic/24.00030


Comparison of Angiographic Result and Long-Term Outcome in Patients With In-Stent Restenosis Treated With Cutting Balloon or With Scoring Balloon Angioplasty

Juergen Leick, MD; Tobias Rheude, MD; Salvatore Cassese, MD; Tobias Krause, MD; Anida Gjata, MD; Louai Saad, MD; Michael Lindner, MD; Mirjam Steinbach, MD; Adnan Kastrati, MD; Nikos Werner MD

J INVASIVE CARDIOL 2024;36(10). doi:10.25270/jic/24.00070

  Watch the accompanying author interview.


Evaluating the Hemodynamic Impact of Saddle Versus Non-Saddle Pulmonary Embolism: Insights From a Thrombectomy Cohort

Robert S. Zhang, MD; Eugene Yuriditsky, MD; Eric Bailey, MD; Lindsay Elbaum, MD; Allison A. Greco, MDRadu Postelnicu, MDVikramjit Mukherjee, MD; Norma Keller, MD; Carlos L. Alviar, MD; James M. Horowitz, MD; Sripal Bangalore, MD, MHA

J INVASIVE CARDIOL 2024;36(12). doi:10.25270/jic/24.00156



Transcript:

Hello, I'm Dr Deepak Bhatt, the editor-in-chief of the Journal of Invasive Cardiology. I'm really happy to share with you our top 10 articles of 2024. These are the top 10 original articles, but of course, there are lots of great images, and we have a top 10 for images as well. But here I'm focusing on the top 10 articles. I’m not putting them in any particular order, I'm just starting from January and going through December of 2024.

00:41: The first one I'll mention is one on acute coronary occlusion and PCI after out-of-hospital cardiac arrest, an area that's been controversial. There's been some data, and not all of it's been concordant. But this is some great work from the Mayo Clinic examining this topic in an observational database.

01:02: The next one I'll mention is on sensor-guided TAVR that came out of Josep Rodés-Cabau’s group, and this is looking at a novel support wire for use in TAVR. This particular wire, called the SAVVY wire, was something that was used to provide a hemodynamic evaluation as well as rapid pacing during TAVR—sort of a 2 for 1. So, it seemed like a really interesting concept and device.

01:37: The next one I'm going to mention is on coronary physiology and the instantaneous wave free ratio, or iFR, but derived from x-ray angiography using artificial intelligence and deep learning.

So those are hot topics, everyone's talking about AI these days. And this is some nice work from Fausto Pinto's group looking at the use of these advanced techniques to determine the iFR, but without actually doing an iFR, that is, using the actual images that are gained anyway during a cardiac catheterization. So, a really interesting concept bringing AI to the Cath lab.

02:23: The next article is an update on CTO PCI, also a hot topic, at least in the interventional world, from Dr Brilakis’s group. For those of you that are thinking about doing CTOS or are doing them and want to do more advanced CTOS, I think this is a really nice, timely update on CTOs.

02:50: The next article I'm going to mention is a comparison between different radial artery compression devices. I think this is an important article, because there's increasing use of the radial approach. Of course, in many parts of the world that's been going on for a while, but in the United States, now, I think the national numbers are up to 40, 50%, maybe they've crossed that threshold. So transradial is really catching on, but an area of debate remains: what's the best way to deal with hemostasis afterwards? So here are some more data from these authors on that topic.

03:24: The next article is about hybrid robotic-assisted coronary revascularization and TAVR. This is a single-center experience, looking at something that probably a lot of places aren't doing, but doing the surgery for revascularization using a robotic approach and then using TAVR from a percutaneous approach. So, I'm not sure when people talk about hybrid, many people even thought of doing it this way. I found it interesting that the authors did this with carefully selected patients and had good outcomes.

04:04: The next article I'm going to mention is one that comes up if you do a lot of angiography, and it's transient internal mammary artery graft stenosis when you do an early angio in cases of hybrid revascularization. So, a little bit more about hybrid approaches. This is the more conventional coronary hybridization that is surgical and percutaneous treatment of a patient. And what the authors find is that the majority of clinically silent LIMA graft stenosis just resolve on their own during follow-up and aren't associated with any adverse clinical outcomes. The key word there is clinically silent. Obviously, if somebody's symptomatic and has an early LIMA stenosis or problem that would have to be addressed. But here it's just urging a little caution in those patients who are asymptomatic.

04:52: The next article has to do with COVID-19 pandemic data from the UK-ReVasc Registry in terms of complex PCI and patients that were unable to undergo CABG because of the pandemic, and I thought this was interesting. Many of you probably, say all of you, unless you're relatively young trainees, lived through the pandemic and practiced through the pandemic, and it was a challenge many times delivering care in that setting, and the authors here talk about patients where CABG would have been ideally done if there weren't a pandemic. But they instead went ahead with complex PCI and it turned out that the outcomes looked pretty good. Obviously, that's not randomized data, but still reassuring to see that when you have to do complex PCI for whatever reason—in this case it was a pandemic, but perhaps it could have been patient preference or other sorts of constraining factors—that the outcomes in careful hands seem pretty good.

05:54: The next article I'll mention is one that looks at different ways of treating in-stent restenosis with a cutting balloon or a scoring balloon and, bottom line, showing that both approaches are really quite good. One isn't so obviously better than the other, and I think these are the sorts of data, observational data, where nobody's doing randomized clinical trials, but still having some data to help guide clinical practice on a daily basis is useful.

6:19: And the final article I'll mention comes out of NYU—actually, the senior author is a former fellow of mine, Sripal Bangalore—and what this experience looked at was hemodynamic impacts of saddle vs non-saddle pulmonary emboli. And what the authors found here was that among patients undergoing catheter-based thrombectomy, that there was no real difference in invasive hemodynamic parameters or clinical outcomes between those with saddle or non-saddle PE. So again, at least in the context of careful hands and PE team, outcomes that seem pretty good, including in those patients with saddle emboli, where in general those patients do poorly. But the caveat, you know, it's observational data and a careful selection of patients with really skilled operators.

So those are our top 10. In fact, we had a lot of great articles last year in the Journal of Invasive Cardiology, so it's always a bit of an arbitrary selection process which ones make it into these sorts of top 10 lists. I'm really grateful to all our authors for their submissions this past year. For those of you that are looking for a place for articles on the broad spectrum of invasive cardiology, whether it's complex coronary intervention, structural heart disease, venous intervention, peripheral, arterial intervention, other forms of intervention, catheterization techniques, EP techniques, really anything in the broad umbrella of invasive cardiology, we publish articles that are original research, occasionally publish review articles, and also still do publish images and case reports. If you think you've got something really interesting, please do send it in.

Thank you to all our authors and thank you to our readers. Hopefully, the journal continues to provide a really useful, clinically actionable service to you. Thank you.

© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates.